{
    "2020-10-29": [
        [
            {
                "time": "",
                "original_text": "泰格医药(03347)前三季度归母净利同比增加149.575至13.18亿元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利",
                        "同比增加",
                        "149.57%",
                        "13.18亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药政改革推动创新浪潮 中国最大临床CRO如何起舞∣全景云调研",
                "features": {
                    "keywords": [
                        "药政改革",
                        "创新浪潮",
                        "临床CRO"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(03347.HK)：将回购注销2.56万股限制性A股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "回购注销",
                        "限制性A股",
                        "2.56万股"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)：前三季度净利升149.57%至13.18亿元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利",
                        "同比上升",
                        "149.57%",
                        "13.18亿元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药(300347.SZ)第三季度归母净利润同比增长81.37%至3.19亿元",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "归母净利润",
                        "同比增长",
                        "81.37%",
                        "3.19亿元"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：前三季度净利润同比增长149.57%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利润",
                        "同比增长",
                        "149.57%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一图流|2019年CRO规模企业盈利能力对比",
                "features": {
                    "keywords": [
                        "CRO",
                        "规模企业",
                        "盈利能力",
                        "对比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "临床CRO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "中医药将进入高速发展黄金时期，这些医药股龙头值得关注",
                "features": {
                    "keywords": [
                        "中医药",
                        "高速发展",
                        "黄金时期",
                        "医药股龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "中医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}